Advisory Team

The Advisory Team at the Collaborative Trajectory Analysis Project consists of 15 experienced advisors who provide strategic guidance and expert insights to advance drug development for Duchenne muscular dystrophy. They work collaboratively to solve critical clinical challenges and support the formulation of innovative therapeutic approaches.